##semicolon##
миелодиспластический синдром, гематологические показатели, общий анализ крови, миелограмма, цитопения, анемия.##submission.citations##
Adès L., Itzykson R., Fenaux P. Myelodys-plastic syndromes //The Lancet. – 2014. – Т. 383. – №. 9936. – С. 2239-2252.
Bejar R. Clinical and genetic predictors of prognosis in myelodysplastic syndromes //Haema-tologica. – 2014. – Т. 99. – №. 6. – С. 956.
Bernard E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes //NEJM evidence. – 2022. – Т. 1. – №. 7. – С. EVIDoa2200008.
Bersanelli M. et al. Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes //Journal of Clinical Oncology. – 2021. – Т. 39. – №. 11. – С. 1223.
Bono E. et al. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome //Leukemia. – 2019. – Т. 33. – №. 10. – С. 2495-2505.
Cazzola M. Myelodysplastic syndromes //New England Journal of Medicine. – 2020. – Т. 383. – №. 14. – С. 1358-1374.
Gangat N., Patnaik M. M., Tefferi A. Myelodysplastic syndromes: Contemporary review and how we treat //American journal of hematology. – 2016. – Т. 91. – №. 1. – С. 76-89.
Grignano E. et al. Autoimmune manifestations associated with myelodysplastic syndromes //Annals of Hematology. – 2018. – Т. 97. – С. 2015-2023.
Invernizzi R., Quaglia F., Della Porta M. G. Importance of classical morphology in the diagnosis of myelodysplastic syndrome //Mediterranean journal of hematology and infectious diseases. – 2015. – Т. 7. – №. 1.
Locatelli F., Strahm B. How I treat myelodysplastic syndromes of childhood //Blood, The Journal of the American Society of Hematology. – 2018. – Т. 131. – №. 13. – С. 1406-1414.
Wlodarski M. W. et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adoles-cents //Blood, The Journal of the American Society of Hematology. – 2016. – Т. 127. – №. 11. – С. 1387-1397.